Genetic architecture of tuberculosis resistance in a mouse model of infection

Genes and Immunity

Volumn 7, Issue 3, 2006, Pages 201-210

  Yan, B S ^a   Kirby, A ^b   Shebzukhov, Y V ^a,d   Daly, M J ^b,c   Kramnik, I ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Gene; Mouse; QTL; Susceptibility; Tuberculosis

Indexed keywords

BINDING PROTEIN; INTRACELLULAR PATHOGEN RESISTANCE 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME 7; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE LOCUS; GENE STRUCTURE; GENETIC VARIABILITY; HEREDITY; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; LINKAGE ANALYSIS; LUNG TUBERCULOSIS; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, CONGENIC; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 33646127180     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364288     Document Type: Article

References (46)

1. Bleed D, Dye C, Raviglione MC. Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med 2000; 6: 174-179.
2. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 2002; 20: 581-620.
3. Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2001; 2: 373-400.
4. Lynch CJ, Pierce-Chase CH, Dubos R. A genetic study of susceptibility to experimental tuberculosis in mice infected with mammalian tubercle bacilli. J Exp Med 1965; 121: 1051-1070.
5. Lurie MB, Zappasodi P, Dannenberg Jr AM, Weiss GH. On the mechanism of genetic resistance to tuberculosis and its mode of inheritance. Am J Hum Genet 1952; 4: 302-314.
6. Musa SA, Kim Y, Hashim R, Wang GZ, Dimmer C, Smith DW. Response of inbred mice to aerosol challenge with Mycobacterium tuberculosis. Infect Immun 1987; 55: 1862-1866.
7. Medina E, North RJ. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 1998; 93: 270-274.
8. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22: 599-623.
9. Brett S, Orrell JM, Swanson Beck J, Ivanyi J. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 1992; 76: 129-132.
10. Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 2001; 69: 2666-2674.
11. Kamath AB, Alt J, Debbabi H, Behar SM. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect Immun 2003; 71: 4112-4118.
12. Kramnik I, Demant P, Bloom BB. Susceptibility to tuberculosis as a complex genetic trait: Analysis using recombinant congenic strains of mice. Novartis Found Symp 1998; 217: 120-131.
13. Kramnik I, Dietrich WF, Demant P, Bloom BR. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2000; 97: 8560-8565.
14. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434: 767-772.
15. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
16. Kruglyak L, Lander ES. A nonparametric approach for mapping quantitative trait loci. Genetics 1995; 139: 1421-1428.
17. Symons RC, Daly MJ, Fridlyand J, Speed TP, Cook WD, Gerondakis S et al. Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice. Proc Natl Acad Sci USA 2002; 99: 11299-11304.
18. Parsons M, Herzenberg LA, Stall AM, Herzenberg LA. Chapter 97. Mouse immunoglobulin allotypes. In: Weir DM (ed.) Handbook of Experimental Immunology. Blackwell Scientific Publ.: Oxford, 1986, pp. 97.1-97.17.
19. Wade CM, Kulbokas III EJ, Kirby AW, Zody MC, Mullikin JC, Lander ES et al. The mosaic structure of variation in the laboratory mouse genome. Nature 2002; 420: 574-578.
20. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350: 423-426.
21. Turner J, Frank AA, Brooks JV, Gonzalez-Juarrero M, Orme IM. The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp Gerontol 2001; 36: 537-545.
22. Vordermeier HM, Venkataprasad N, Harris DP, Ivanyi J. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996; 106: 312-316.
23. Bosio CM, Gardner D, Elkins KL. Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology. J Immunol 2000; 164: 6417-6425.
24. Johnson CM, Cooper AM, Frank AA, Bonorino CB, Wysoki LJ, Orme IM. Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. Tuberc Lung Dis 1997; 78: 257-261.
25. Huygen K, Ljungqvist L, ten Berg R, Van Vooren JP. Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect Immun 1990; 58: 2192-2197.
26. Brett SJ, Ivanyi J. Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology 1990; 71: 113-119.
27. Bosio CM, Elkins KL. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun 2001; 69: 194-203.
28. Schrier DJ, Sternick JL, Allen EM, Moore VL. Genetic basis of BCG-induced suppression of delayed hypersensitivity. Nature 1981; 289: 405-407.
29. Schrier DJ, Sternick JL, Allen EM, Moore VL. Immunogenetics of BCG-induced anergy in mice: Control by genes linked to the Igh complex. J Immunol 1982; 128: 1466-1469.
30. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.
31. Apt AS, Avdienko VG, Nikonenko BV, Kramnik IB, Moroz AM, Skamene E. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol 1993; 94: 322-329.
32. Sanchez F, Radaeva TV, Nikonenko BV, Persson AS, Sengul S, Schalling M et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect Immun 2003; 71: 126-131.
33. Asherson GL, Dieli F, Gautam Y, Siew LK, Zembala M. Major histocompatibility complex regulation of the class of the immune response: The H-2d haplotype determines poor interferon-gamma response to several antigens. Eur J Immunol 1990; 20: 1305-1310.
34. Kamath AB, Alt J, Debbabi H, Taylor C, Behar SM. The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice. Infect Immun 2004; 72: 6790-6798.
35. Algood HM, Lin PL, Flynn JL. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 2005; 41 (Suppl 3): S189-S193.
36. Kahler AK, Persson AS, Sanchez F, Kallstrom H, Apt AS, Schurr E et al. A new coding mutation in the Tnf-alpha leader sequence in tuberculosis-sensitive I/St mice causes higher secretion levels of soluble TNF-alpha. Genes Immun 2005; 6: 620-627.
37. Skamene E, Schurr E, Gros P. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annu Rev Med 1998; 49: 275-287.
38. North RJ, LaCourse R, Ryan L, Gros P. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice. Infect Immun 1999; 67: 5811-5814.
39. Malik S, Abel L, Tooker H, Poon A, Simkin L, Girard M et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci USA 2005; 102: 12183-12188.
40. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
41. Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol 1996; 157: 3559-3568.
42. Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North RJ et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun 2000; 1: 467-477.
43. Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci USA 2003; 100: 6610-6615.
44. Kramnik I, Boyartchuk V. Immunity to intracellular pathogens as a complex genetic trait. Curr Opin Microbiol 2002; 5: 111-117.
45. Casanova JL, Abel L. Inborn errors of immunity to infection: The rule rather than the exception. J Exp Med 2005; 202: 197-201.
46. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.